Diabetes mellitus in a domesticated Spanish mustang.

The research article focuses on a case of diabetes mellitus in an 18-year-old Spanish Mustang mare which appears to be due to a failure in the horse’s pancreatic beta cells, responsible for insulin secretion.

Case Presentation

• The piece begins with the case of an 18-year-old Spanish Mustang mare that had been referred for veterinary evaluation due to progressive weight loss and persistent high blood sugar levels.
• The clinical examinations revealed abnormal levels of hyperglycemia and glycosuria (excess sugar in urine). These pointed towards a possible metabolic disorder, specifically diabetes mellitus, a condition where the body does not produce sufficient insulin or cannot effectively use the insulin it produces. This leads to elevated levels of glucose in the blood, known as hyperglycemia.

Diagnostic Tests

• The researchers conducted several tests to identify the cause of the horse’s condition. These included a dexamethasone suppression test, which showed that the horse did not have any disorders associated with the pituitary gland (which can also cause similar symptoms).
• Tests showed that the mare’s serum insulin and plasma C-peptide concentrations were low, suggesting that the hyperglycemia might be due to decreased secretion of insulin from the pancreas’s beta cells.
• Further examination showed that the glucose concentration had a delayed return to the baseline even after administering a glucose bolus intravenously. This suggested that insulin secretion or both the secretion and its effects were reduced.

Treatment

• The researchers attempted treatment using glyburide and metformin. These are drugs commonly used to treat human diabetes. This approach successfully brought the horse’s glucose level back within reference (normal) limits within five hours.

Post-Mortem Examination

• Despite the successful response to treatment, the horse was euthanized and a post-mortem examination was performed to understand the cause of the condition. This post-mortem examination revealed a decrease in the beta-cell population within the pancreatic islets. Additionally, the cells that were present were limited to the periphery of these islets.
• This confirmed that the horse’s condition was due to impaired insulin production owing to the abnormality in pancreatic beta cells.

Conclusion

• The researchers thus concluded that while it is rare, failure of the pancreatic beta cells can contribute to the development of diabetes mellitus in horses. This case report contributes to our understanding of equine diabetes mellitus and suggests further research might be warranted in this area.